Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous naloxone to prevent pruritus from intrathecal pethidine in minor surgery
IRCT2017021210222N8Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of naloxone in pruritus, sponsored by Shahrekord University of Medical Sciences. Started Mar 2017; status: completed.
02
Drugs
naloxone
03
Conditions
pruritus
Beyond the preview
Go deeper on IRCT2017021210222N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017021210222N8.